N-Nitroso Tofacitinib

It is an impurity present in Tofacitinib. Tofacitinib is a small-molecule Janus-associated kinase inhibitor, which is used for the treatment of adult patients with moderate to severe rheumatoid arthritis. Also it has had an inadequate response or intolerance to methotrexate therapy.

Additional information on N-Nitroso Tofacitinib

Catalogue No.

VE009521

CAS No.

N/A

Molecular Formula

C16H19N7O2

Molecular Weight

341.4 g//mol

Parent drug

Tofacitinib

IUPAC Name

3-((3R, 4R)-4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

Synonyms

Tofacitinib Nitroso Impurity 1

References

Cada, D. J., Demaris, K., Levien, T. L., & Baker, D. E. (2013). Tofacitinib. Hospital Pharmacy, 48(5), 413–424. https://doi.org/10.1310/hpj4805-413

Status

Under Development

[rfq_list]

Login first to add product to RFQ List

Request a quote

N-Nitroso Tofacitinib

N-Nitroso Tofacitinib
Catalogue No.

VE009521

CAS No.

N/A

Molecular Formula

C16H19N7O2

Molecular Weight

341.4 g//mol

Parent drug

Tofacitinib

IUPAC Name

3-((3R, 4R)-4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile

Synonyms

Tofacitinib Nitroso Impurity 1

References

Cada, D. J., Demaris, K., Levien, T. L., & Baker, D. E. (2013). Tofacitinib. Hospital Pharmacy, 48(5), 413–424. https://doi.org/10.1310/hpj4805-413

Status

Under Development

ListName

N-Nitroso Tofacitinib

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden